Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
alt text
sign up
Rangers International Football Club plc
Company Name:Rangers International Football Club plc Minimum fundraise:£0.00* High Share Price Bid:£0.25
Business Sector:Entertainment and Leisure Total Funds Bid to Date:£0.00 Low Share Price Bid:£0.05
Auction period:29 Jan 2026 - 29 Apr 2026 Indicative Share Price:0.00 Average Share Price Bid:£0.13**
Company Details Below
*The company will accept oversubscription.
**In the event of significant oversubscription, shares will be allocated to bids at the average price and above.
NOTE: ASSET MATCH HAS NEGOTIATED AN “ASSET MATCH INVESTOR BONUS” FOR INVESTORS IN THIS TRANSACTION. SEE THE “OVERVIEW” SECTION BELOW FOR DETAILS.

Need help?
+44 (0) 207 248 2788

back

Rangers International Football Club plc

Rangers International Football Club plc

Market Cap: £9,483,346 Auction period: 29 Jan 2026 - 29 Apr 2026 Indicative price: 0.00

Live Started 82 days ago

Lowest Offer 1.50p

Auction closes in 8 days


BUY ORDERS SELL ORDERS

BuyersShares Wanted Total Wanted Share Price (p)
-- -- -- 1.50
-- -- -- 2.00
-- -- -- 3.00
-- -- -- 3.25
       
Share Price (p) Total Offered Shares OfferedSellers
1.50 4,471 4,471 1
2.00 10,471 6,000 1
3.00 19,679 9,208 3
3.25 25,627 5,948 2
       

BUY ORDERS

SELL ORDERS

Buyers Shares Total Shares Share Price (p) Total Shares Shares Sellers
-- -- -- 1.50 4,471 4,471 1
-- -- -- 2.00 10,471 6,000 1
-- -- -- 3.00 19,679 9,208 3
-- -- -- 3.25 25,627 5,948 2
             

Interested in Rangers International Football Club plc?
Register or log in to participate, create a watchlist, or set reminder

Register Log in

Company info

Warning! No Formal Relationship
Rangers International Football Club plc has been admitted to trading on Asset Match at the request of a number of its shareholders. Asset Match has no formal relationship with Rangers. Investors should understand the risks fully before investing.

Rangers International Football Club plc is the corporate entity of Rangers Football Club, a Scottish professional football club based in Glasgow. Founded in 1872, Rangers F.C. is the fourth‑oldest football club in Scotland and competes in the Scottish Premiership. The club is the most successful in Scottish football history, having won a record 55 league championships.

In 2025, Rangers International Football Club plc underwent a significant ownership transition when a consortium of investors led by Andrew Cavenagh, alongside 49ers Enterprises, acquired a majority shareholding in the company, following approval from the Scottish Football Association. The new ownership group committed to fresh investment into the club and appointed Cavenagh as Chairman, supported by Paraag Marathe as Vice‑Chairman. The consortium has outlined a strategic focus on improving on‑pitch performance while ensuring long‑term financial sustainability under strengthened governance.

The company’s principal assets include Ibrox Stadium, one of the UK’s most iconic football venues, and the club’s modern training facility at Murray Park, both of which underpin Rangers F.C.’s domestic and European ambitions.

www.rangers.co.uk

Rangers International Football Club Auction Details

Rangers International Football Club plc was admitted to trading on Asset Match on 20 March 2023 at a price of 25 pence per share (being the equivalent to the last funding round via Tifosy).

Auctions are held quarterly and close at 4pm on the last Wednesday of the month (unless stated otherwise).

The tick size for this company is 0.25 pence per share.

Please read the auction instructions section below for more information on how to participate.

Rangers International Football Club Price History (last 10)

Enlarge

Auction instructions

Buying and Selling Shares via Asset Match Private Market

To buy or sell shares in this company through the Asset Match Private Market, you will need to use a stockbroker.

If you already have an existing relationship with a UK broker on our approved broker list, you should be able to place an order to participate directly through them.

If you do not currently have a broker, please contact us and we will provide guidance on suitable options.

If you require assistance or have any questions about participating, please contact us:

📧 dealing@assetmatch.com

📞 +44 (0)20 7248 2788

Fees

When buying or selling shares, an Asset Match levy of 3% applies, with a minimum charge of £20 per trade (additional broker fees may also apply).

For more information on how the auction process works, please click here.

Key People

Andrew

Andrew Cavenagh Chairman

Andrew Cavenagh is the Chairman of Rangers Football Club and a successful entrepreneur, chief executive, and investor with decades of business experience. In 2025, he led the investment consortium that acquired a controlling stake in Rangers and injected additional capital into the club. Having spent most of his career in the insurance industry, Cavenagh’s leadership and innovative mindset has enabled him to reshape the health insurance landscape. He has founded three insurance companies, including ParetoHealth, which he started in 2011 and has since grown into a transformative company whose clients insure over 1 million people. He currently serves as Executive Chairman of ParetoHealth after serving as the company’s CEO for 14 years. As a founder and innovator, Cavenagh has decades of experience raising capital and strategically allocating it to build and sustain successful business models. Equally important, he has a proven track record of developing talent by empowering the right people in the right roles to drive results. A life-long football fan, Cavenagh has always relished the opportunity to attend matches to experience in-person the passion and incredible atmosphere that supporters bring to the game. He has attended multiple World Cup and European Championships, along with countless club matches. Ultimately, it was Ibrox and the Rangers supporters that drew him to invest in the club. Cavenagh graduated with a degree in economics from Swarthmore College in Pennsylvania, where he also had a four-year collegiate football career as an award-winning goalkeeper and captain. While he makes frequent trips to Glasgow, his permanent residence is in Pennsylvania with his family.
   
Jim

Jim Gillespie Chief Executive Officer

Jim Gillespie is the incoming Chief Executive Officer (CEO) of Rangers Football Club, appointed in January 2026 to succeed Patrick Stewart. Formerly the vice-chairman of St Mirren and CEO of the Kibble social care charity, Gillespie was chosen for his strong leadership experience to lead operations and support the club's footballing ambitions.
   
Fraser

Fraser Thornton Director

Fraser has held many senior leadership and board positions throughout his career, in both private and public companies. Having worked in the international drinks industry for the last 30 years, he offers a vast range of experience in stakeholder engagement; spanning political, commercial and public interest groups. He has extensive management experience across sales, brand marketing, strategy development and finance. Raised in Glasgow, Fraser graduated from the University of Stirling before qualifying as a Chartered Accountant with Price Waterhouse in Glasgow in 1993. Between 1996 and 2021, Fraser held multiple executive leadership positions in international businesses working across several regions of the world. He was a council member of the Scotch Whisky Association for 15 years until 2021. Since 2021 Fraser has built a portfolio of non-executive roles across the Scottish corporate landscape.
   
John

John Halstead Director

John Halsted, an American investor, has over 30 years of private equity experience. Currently based in Wyoming, his business interests span the United States and Europe. He was a founding partner of Pamplona Capital Partners, leading the firm to excel in global investment activities across sectors such as life sciences, energy, industrial, technology, and retail. Over his 20-year tenure there, he held pivotal roles, including Chief Investment Officer, President, and Managing Partner. Prior to forming his company, he worked as an investment executive at Beacon Capital Partners and the Harvard Private Equity Group, an investment arm of the Harvard University Endowment. He has a Bachelor of Arts in Economics from the University of California, Berkeley, and a Masters in Business Administration from the Harvard Business School. In 2021, he became an investor in Rangers through his family's holding company, Perron Investments, LLC.
   

George Taylor Director

George Taylor is a British investment banker and, since 2022, a non-executive director of Rangers International Football Club PLC (RIFC), the holding company of Rangers Football Club. Born in Glasgow, he has been a prominent figure in the financial sector, particularly in Asia, and has played a significant role in the club's financial restructuring and governance. Taylor's career in investment banking has been distinguished, with a significant tenure at Morgan Stanley, having joined in 2001 and currently serves as the head of Investment Banking for Asia Pacific and Board Member of the Asian Private Bank. George has an undergraduate degree in Geography from Durham University and a post graduate degree from Cambridge University in International Relations. He currently resides in Hong Kong.
   
Andrew

Andrew Clayton Director

Andrew Clayton is a Co-Founder and Vice Chairman of ParetoHealth, a Philadelphia based health insurance solution company. Throughout his nearly 30-year career, Andrew has led growth and strategy efforts for industry leading insurance and risk management companies. Andrew serves on numerous business and philanthropic boards and committees, and has a degree in economics from Swarthmore College.
   
Mark

Mark Taber Director

Mark Taber is a managing director and member of the executive and investment committees at Great Hill Partners, a Boston-based growth equity firm, where he is responsible for transaction origination, investment policy, fundraising, investor relations, and general management of the firm. Mark focuses on healthcare and is a current or former board member of over a dozen healthcare companies, spanning the spectrum of payer, provider, pharmacy and medical devices. Additionally, he is a member of the board of trustees for Boston Medical Center’s HealthNet health plan and a member of the finance committee at BMC. Mark graduated from the J.L. Kellogg Graduate School of Management, where he was an F.C. Austin Scholar and the Jim Packard Memorial Scholar. He also holds a Bachelor of Arts in public policy from Duke University.